Home - AOP Orphan

By selecting a country, you will see contents with local focus. Contents that are not available in the local language, will be shown in English.

Healthcare Professionals

Please log in for special information and services

New here?

sign up for personal account

- Our Company
  
  We at AOP Orphan are European pioneers in the field of rare diseases, researching, developing, producing, and distributing innovative solutions worldwide since 1996. Learn more about the company here.
  About Our Company
- Rare Diseases And Symptoms
  
  We at AOP Orphan focus on rare diseases particularly in the areas of HematoOncology, Cardiology & Pulmonology, Neurology & Metabolic Disorders. Learn more about the indications, its symptoms, diagnosis, therapies and everyday life here.
  About Rare Diseases And Symptoms
  - HematoOncology
    - Essential Thrombocythemia
    - Polycythaemia Vera
  - Cardiology & Pulmonology
  - Neurology & Metabolic Disorders
    - Huntington's disease
    - Tardive Dyskinesia
- Individual Treatments
  
  Our strategic goal at AOP Orphan is to constantly deliver new treatment options for the patients with rare disease. Learn more about the current product portfolio and countries' availability here.
  About Individual Treatments
  - HematoOncology
    - Anagrelide AOP
  - Cardiology & Pulmonology
  - Neurology & Metabolic Disorders
- Join Us
  
  Agile, ambitious and aligned team members, mutual appreciation and commitment - this is what makes AOP Orphan a successful company and great place to work. Learn more about the company, open positions and everyday life at AOP Orphan here.
  About Join Us
  - HR Team & Contacts
  - Jobs

POLYCYTHAEMIA VERA

"I wanted to experience the joy of living, having positive thoughts again.“

Dr. Elena Zagorulko, PV Patient | Head of the MPN Support Group Austria

News

Meet Us Globally

8
Jun.
Bio-International 2020
SAN DIEGO, US
10
Jun.
Virtual Congress
EHA 2020
FRANKFURT, GERMANY
2
Jul.
PH Academy
VIENNA , AUSTRIA

Meet Us in United Kingdom

Science & Innovation

From the Concept to the Drug

AOP Orphan team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.

More on the global website

CONNECTED WORLDWIDE

Partnering

Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe.

More on the global website